Risks and Benefits of Combining Clonazepam and Gabapentin

Primary Safety Concerns

The American College of Oncology recommends that the combination of clonazepam and gabapentin should only be used when the clinical benefit clearly outweighs the risks of additive central nervous system depression, particularly respiratory depression and oversedation, with close monitoring for sedation, respiratory status, and fall risk 1, 2
The combination of benzodiazepines like clonazepam with other CNS depressants carries a significant risk of additive respiratory depression, and there is an increased incidence of apnea when benzodiazepines are combined with other sedative agents, requiring preparation to provide respiratory support 3, 4
Fatalities have been reported with concurrent use of benzodiazepines with other CNS depressants, particularly at higher doses, and the combination significantly increases fall risk, particularly in elderly or frail patients 1, 2

The American Academy of Pediatrics recommends evaluating respiratory function baseline, particularly screening for sleep apnea, as clonazepam at doses as low as 0.5 mg can worsen obstructive sleep apnea, and performing fall risk assessment, especially in elderly patients, as both medications increase confusion and motor incoordination 6
Monitor for excessive sedation, particularly during the first 2-4 weeks of combined therapy, and watch for signs of respiratory depression including decreased respiratory rate, shallow breathing, or oxygen desaturation 3, 4, 6

The American Geriatrics Society recommends using lower doses in older or frail patients, or in patients with COPD when combining CNS depressants, and beginning at a low level and increasing slowly, as side effects tend to be dose-related and occur early in therapy 1, 2

The American Geriatrics Society Beers Criteria lists clonazepam as potentially inappropriate in older adults, and contraindications include untreated obstructive sleep apnea, severe cognitive impairment, or significant fall risk, as well as severe pulmonary insufficiency, severe liver disease, or myasthenia gravis 6, 1, 2

Physical dependence develops with prolonged benzodiazepine use, and patients typically cannot substantially reduce doses despite periodic tapering attempts, with up to 58% of patients experiencing moderate-to-severe side effects with clonazepam 7, 6